These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36980202)

  • 1. B7H4 Expression Is More Frequent in MSS Status Colorectal Cancer and Is Negatively Associated with Tumour Infiltrating Lymphocytes.
    Dawidowicz M; Kula A; Mielcarska S; Kiczmer P; Skiba H; Krygier M; Chrabańska M; Piecuch J; Szrot M; Robotycka J; Ochman B; Strzałkowska B; Czuba Z; Świętochowska E; Waniczek D
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7H3 Role in Reshaping Immunosuppressive Landscape in MSI and MSS Colorectal Cancer Tumours.
    Mielcarska S; Dawidowicz M; Kula A; Kiczmer P; Skiba H; Krygier M; Chrabańska M; Piecuch J; Szrot M; Ochman B; Robotycka J; Strzałkowska B; Czuba Z; Waniczek D; Świętochowska E
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status.
    Michael-Robinson JM; Biemer-Hüttmann A; Purdie DM; Walsh MD; Simms LA; Biden KG; Young JP; Leggett BA; Jass JR; Radford-Smith GL
    Gut; 2001 Mar; 48(3):360-6. PubMed ID: 11171826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
    Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
    J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ in the tumor microenvironment promotes the expression of B7H4 in colorectal cancer cells, thereby inhibiting cytotoxic T cells.
    Jing ZL; Liu GL; Zhou N; Xu DY; Feng N; Lei Y; Ma LL; Tang MS; Tong GH; Tang N; Deng YJ
    Sci Rep; 2024 Mar; 14(1):6053. PubMed ID: 38480774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of Tim3
    Klapholz M; Drage MG; Srivastava A; Anderson AC
    J Pathol; 2022 Jun; 257(2):186-197. PubMed ID: 35119692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression and Role of HHLA2, a Novel Immune Checkpoint, in Colorectal Cancer.
    Kula A; Dawidowicz M; Mielcarska S; Kiczmer P; Skiba H; Krygier M; Chrabańska M; Piecuch J; Szrot M; Robotycka J; Ochman B; Strzałkowska B; Czuba Z; Świętochowska E; Waniczek D
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory receptor CD94/NKG2A on CD8
    Eugène J; Jouand N; Ducoin K; Dansette D; Oger R; Deleine C; Leveque E; Meurette G; Podevin J; Matysiak T; Bennouna J; Bezieau S; Volteau C; Thomas WEA; Chetritt J; Kerdraon O; Fourquier P; Thibaudeau E; Dumont F; Mosnier JF; Toquet C; Jarry A; Gervois N; Bossard C
    Mod Pathol; 2020 Mar; 33(3):468-482. PubMed ID: 31409873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic.
    Phillips SM; Banerjea A; Feakins R; Li SR; Bustin SA; Dorudi S
    Br J Surg; 2004 Apr; 91(4):469-75. PubMed ID: 15048750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7H4 expression in tumor cells impairs CD8 T cell responses and tumor immunity.
    Zhou L; Ruan M; Liu Y; Zhu Y; Fu D; Wu K; Zhang Q
    Cancer Immunol Immunother; 2020 Feb; 69(2):163-174. PubMed ID: 31848656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3- and B7H4-dependent anti-tumor immunity in colorectal cancer.
    Peuker K; Strigli A; Tauriello DVF; Hendricks A; von Schönfels W; Burmeister G; Brosch M; Herrmann A; Krüger S; Nitsche J; Južnić L; Geissler MM; Hiergeist A; Gessner A; Wirbel J; Ponnudurai RP; Tunger A; Wehner R; Stange DE; Weitz J; Aust DE; Baretton GB; Schmitz M; Röcken C; Hampe J; Hinz S; Zeller G; Chavakis T; Schafmayer C; Batlle E; Zeissig S
    Immunity; 2022 Apr; 55(4):701-717.e7. PubMed ID: 35364006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer.
    Thibaudin M; Limagne E; Hampe L; Ballot E; Truntzer C; Ghiringhelli F
    Cancer Immunol Immunother; 2022 Oct; 71(10):2549-2563. PubMed ID: 35292828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
    Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
    J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
    Michael-Robinson JM; Pandeya N; Cummings MC; Walsh MD; Young JP; Leggett BA; Purdie DM; Jass JR; Radford-Smith GL
    J Pathol; 2003 Sep; 201(1):46-54. PubMed ID: 12950016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer.
    Akin Telli T; Bregni G; Vanhooren M; Saude Conde R; Hendlisz A; Sclafani F
    Cancer Treat Rev; 2022 Nov; 110():102460. PubMed ID: 36058142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-inhibitor expression on tumor infiltrating and splenic lymphocytes after dual checkpoint inhibition in a microsatellite stable model of colorectal cancer.
    Slovak RJ; Park HJ; Kamp WM; Ludwig JM; Kang I; Kim HS
    Sci Rep; 2021 Mar; 11(1):6956. PubMed ID: 33772035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7H4 Role in Solid Cancers: A Review of the Literature.
    Dawidowicz M; Kot A; Mielcarska S; Psykała K; Kula A; Waniczek D; Świętochowska E
    Cancers (Basel); 2024 Jul; 16(14):. PubMed ID: 39061159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
    Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
    J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
    Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability.
    Prall F; Dührkop T; Weirich V; Ostwald C; Lenz P; Nizze H; Barten M
    Hum Pathol; 2004 Jul; 35(7):808-16. PubMed ID: 15257543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.